221 related articles for article (PubMed ID: 34691049)
21. Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis.
Harwood R; Yan H; Talawila Da Camara N; Smith C; Ward J; Tudur-Smith C; Linney M; Clark M; Whittaker E; Saatci D; Davis PJ; Luyt K; Draper ES; Kenny SE; Fraser LK; Viner RM
EClinicalMedicine; 2022 Feb; 44():101287. PubMed ID: 35169689
[TBL] [Abstract][Full Text] [Related]
22. Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis.
Vai B; Mazza MG; Delli Colli C; Foiselle M; Allen B; Benedetti F; Borsini A; Casanova Dias M; Tamouza R; Leboyer M; Benros ME; Branchi I; Fusar-Poli P; De Picker LJ
Lancet Psychiatry; 2021 Sep; 8(9):797-812. PubMed ID: 34274033
[TBL] [Abstract][Full Text] [Related]
23. Nosocomial SARS-CoV-2 Infections and Mortality During Unique COVID-19 Epidemic Waves.
Dave N; Sjöholm D; Hedberg P; Ternhag A; Granath F; Verberk JDM; Johansson AF; van der Werff SD; Nauclér P
JAMA Netw Open; 2023 Nov; 6(11):e2341936. PubMed ID: 37948082
[TBL] [Abstract][Full Text] [Related]
24. Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study.
Wong CKH; Au ICH; Lau KTK; Lau EHY; Cowling BJ; Leung GM
Lancet; 2022 Oct; 400(10359):1213-1222. PubMed ID: 36216007
[TBL] [Abstract][Full Text] [Related]
25. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
26. Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
Rosenthal N; Cao Z; Gundrum J; Sianis J; Safo S
JAMA Netw Open; 2020 Dec; 3(12):e2029058. PubMed ID: 33301018
[TBL] [Abstract][Full Text] [Related]
27. Temporal trends of sex differences for COVID-19 infection, hospitalisation, severe disease, intensive care unit (ICU) admission and death: a meta-analysis of 229 studies covering over 10M patients.
Pijls BG; Jolani S; Atherley A; Dijkstra JIR; Franssen GHL; Hendriks S; Yi-Wen Yu E; Zalpuri S; Richters A; Zeegers MP
F1000Res; 2022; 11():5. PubMed ID: 35514606
[No Abstract] [Full Text] [Related]
28. IMPACT-Scot 2 report on COVID-19 in hip fracture patients.
Hall AJ; Clement ND; MacLullich AMJ; White TO; Duckworth AD
Bone Joint J; 2021 May; 103-B(5):888-897. PubMed ID: 33487012
[TBL] [Abstract][Full Text] [Related]
29. Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer: A Systematic Review and Meta-analysis.
Khoury E; Nevitt S; Madsen WR; Turtle L; Davies G; Palmieri C
JAMA Netw Open; 2022 May; 5(5):e2210880. PubMed ID: 35532936
[TBL] [Abstract][Full Text] [Related]
30. Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study.
Jassat W; Mudara C; Ozougwu L; Tempia S; Blumberg L; Davies MA; Pillay Y; Carter T; Morewane R; Wolmarans M; von Gottberg A; Bhiman JN; Walaza S; Cohen C;
Lancet Glob Health; 2021 Sep; 9(9):e1216-e1225. PubMed ID: 34252381
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study.
Agrawal U; Katikireddi SV; McCowan C; Mulholland RH; Azcoaga-Lorenzo A; Amele S; Fagbamigbe AF; Vasileiou E; Grange Z; Shi T; Kerr S; Moore E; Murray JLK; Shah SA; Ritchie L; O'Reilly D; Stock SJ; Beggs J; Chuter A; Torabi F; Akbari A; Bedston S; McMenamin J; Wood R; Tang RSM; de Lusignan S; Hobbs FDR; Woolhouse M; Simpson CR; Robertson C; Sheikh A
Lancet Respir Med; 2021 Dec; 9(12):1439-1449. PubMed ID: 34599903
[TBL] [Abstract][Full Text] [Related]
32. Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small number of highly infectious individuals.
Lumley SF; Constantinides B; Sanderson N; Rodger G; Street TL; Swann J; Chau KK; O'Donnell D; Warren F; Hoosdally S; ; ; O'Donnell AM; Walker TM; Stoesser NE; Butcher L; Peto TE; Crook DW; Jeffery K; Matthews PC; Eyre DW
J Infect; 2021 Oct; 83(4):473-482. PubMed ID: 34332019
[TBL] [Abstract][Full Text] [Related]
33. Remdesivir for the treatment of COVID-19.
Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014962. PubMed ID: 34350582
[TBL] [Abstract][Full Text] [Related]
34. Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU: A Systematic Review and Meta-analysis.
Tan E; Song J; Deane AM; Plummer MP
Chest; 2021 Feb; 159(2):524-536. PubMed ID: 33069725
[TBL] [Abstract][Full Text] [Related]
35. Convalescent plasma for people with COVID-19: a living systematic review.
Iannizzi C; Chai KL; Piechotta V; Valk SJ; Kimber C; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Jindal A; Cryns N; Estcourt LJ; Kreuzberger N; Skoetz N
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013600. PubMed ID: 36734509
[TBL] [Abstract][Full Text] [Related]
36. Nosocomial COVID-19. Prospective study in a referral hospital.
Escolà-Vergé L; Borràs-Bermejo B; Los-Arcos I; Esperalba J; Ferrer C; Fernández-Hidalgo N
Med Clin (Barc); 2022 Aug; 159(3):134-136. PubMed ID: 34384612
[TBL] [Abstract][Full Text] [Related]
37. Antibiotics for the treatment of COVID-19.
Popp M; Stegemann M; Riemer M; Metzendorf MI; Romero CS; Mikolajewska A; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD015025. PubMed ID: 34679203
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 nosocomial infection acquired in a French university hospital during the 1st wave of the Covid-19 pandemic, a prospective study.
Landoas A; Cazzorla F; Gallouche M; Larrat S; Nemoz B; Giner C; Le Maréchal M; Pavese P; Epaulard O; Morand P; Mallaret MR; Landelle C
Antimicrob Resist Infect Control; 2021 Aug; 10(1):114. PubMed ID: 34353356
[TBL] [Abstract][Full Text] [Related]
39. Community-acquired viral respiratory infections amongst hospitalized inpatients during a COVID-19 outbreak in Singapore: co-infection and clinical outcomes.
Wee LE; Ko KKK; Ho WQ; Kwek GTC; Tan TT; Wijaya L
J Clin Virol; 2020 Jul; 128():104436. PubMed ID: 32447256
[TBL] [Abstract][Full Text] [Related]
40. Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
Juul S; Nielsen EE; Feinberg J; Siddiqui F; Jørgensen CK; Barot E; Holgersson J; Nielsen N; Bentzer P; Veroniki AA; Thabane L; Bu F; Klingenberg S; Gluud C; Jakobsen JC
PLoS One; 2021; 16(3):e0248132. PubMed ID: 33705495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
